En Es
Categories

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of human diseases, such as tuberculosis, strep throat, pneumonia, and sexually transmitted diseases, as well as for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) contamination of bloo ...
Products Covid-19NewsSummary
Close

Covid-19 Hologic

Clinical Laboratory

SARS-CoV-2 Assay
Panther Fusion SARS-CoV-2 assay

The Panther Fusion SARS-CoV-2 assay is a real-time PCR in vitro diagnostic test utilizing Hologic's proprietary TMA technology for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal, nasal and oropharyngeal swab specimens and lower respiratory tract specimens obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria. The assay runs on both Hologic's Panther® and Panther Fusion systems®, enabling labs to run over 10,00 tests in 24 hours and attain first results in 3.5 hours or less.
More details

SARS-CoV-2 Assay
Aptima SARS-CoV-2 assay

The Aptima SARS-CoV-2 assay is an in vitro diagnostic test utilizing Hologic's proprietary TMA technology for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal, nasal and oropharyngeal swab specimens obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria. The assay runs on both Hologic's Panther® and Panther Fusion systems®, enabling labs to run over 10,00 tests in 24 hours and attain first results in 3.5 hours or less.
More details
Close

News of Hologic

Hologic Showcased Latest Advances at Virtual ECR Congress 2020

20 Aug 2020
Hologic Showcased Latest Advances at Virtual ECR Congress 2020
Hologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.
Read More

Hologic to Sell Blood-Screening Business to Grifols for USD 1.85 Billion

15 Dec 2016
Hologic to Sell Blood-Screening Business to Grifols for USD 1.85 Billion
US medical device maker Hologic, Inc. has agreed to sell off its share of the Procleix blood-screening business to long-time partner, Grifols SA, for USD 1.85 billion in cash.
Read More
Close

About Hologic

Number of Employees: 1000+
Year of Establishment: 1986
Designs and provides products for clinical laboratory and blood screening, including testing items for detection of human diseases, such as tuberculosis, strep throat, pneumonia, and sexually transmitted diseases, as well as for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) contamination of blood supply
FaceBook Twitter Google+ Linked in
Breast Stabilization System

Breast Stabilization System

Model: SmartCurve
Request Information

Description:

The SmartCurve breast stabilization system provides a curved compression surface that offers a more comfortable patient experience without compromising image quality, exam time, dose or workflow. Clinically proven to deliver a more comfortable mammogram, it improves comfort in 93% of patients who reported moderate to severe discomfort with standard compression.


Send A Message To This Supplier

* Required Information
* Email
To
Hologic (Breast Stabilization System)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions